Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Alfresa Holdings ( (JP:2784) ) is now available.
Alfresa Holdings will seek shareholder approval at its 23rd Ordinary General Meeting on June 24, 2026, to revise its Articles of Incorporation and shift its method of corporate public notices from newspaper publication in the Nihon Keizai Shimbun to electronic disclosure. The change, which is scheduled to take effect on the same day, is designed to improve accessibility of corporate information for investors and other stakeholders while streamlining administrative procedures, with a contingency to revert to newspaper notices if electronic publication becomes temporarily unavailable.
The move aligns Alfresa with a broader digitalization trend in Japanese corporate governance and investor communications, potentially reducing costs and speeding the dissemination of legally required disclosures. For shareholders and market participants, the transition to electronic public notices is expected to make it easier to track company announcements in real time and may enhance transparency and operational efficiency as the group continues to manage its extensive healthcare-related businesses across Japan.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2400.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
The Alfresa Group is a major player in Japan’s healthcare sector, operating across ethical and OTC pharmaceutical wholesaling, pharmaceutical manufacturing, dispensing pharmacies, regenerative medicine, and CRO services. Listed on the Tokyo Stock Exchange under ticker 2784, Alfresa Holdings reported consolidated revenue of ¥3.1 trillion for the year ended March 31, 2026, underscoring its scale and central role in the domestic healthcare supply chain.
Average Trading Volume: 353,006
Technical Sentiment Signal: Buy
Current Market Cap: Yen444.6B
For an in-depth examination of 2784 stock, go to TipRanks’ Overview page.